Physician profile
Edwin A Lee
NPI 1629244918
$27,157.55
in general payments reported to CMS, 2019-2025
34 companies · $2,836 in 2025
The $2,836 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,419 · 2020: $4,735 · 2021: $5,263 · 2022: $6,317 · 2023: $1,878 · 2024: $2,710 · 2025: $2,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,334 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,334.10 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10,886.22 | 2019-2025 | Lifevest |
| Abbott Laboratories | $6,216.66 | 2019-2025 | Gallant, Aveir, Pressurewire |
| Bayer Healthcare Pharmaceuticals INC. | $1,442.51 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,116.67 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $981.69 | 2019-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $790.91 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Medtronic, INC. | $695.17 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Advisa Dr Mri Surescan |
| Amgen INC. | $595.77 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $570.03 | 2022-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $497.16 | 2023-2025 | Jardiance |
| Shockwave Medical, INC | $466.77 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $432.58 | 2020-2024 | |
| Astellas Pharma US INC | $343.39 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $216.49 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $198.64 | 2022-2025 | Assure Wcd |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $196.24 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $191.06 | 2024 | Arcalyst |
| Novo Nordisk INC | $182.15 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Penumbra, INC. | $148.69 | 2022 | |
| Heartflow, INC. | $140.97 | 2024-2025 | |
| Bardy Diagnostics, INC. | $136.89 | 2021 | |
| Impulse Dynamics (USA) INC. | $131.44 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $102.64 | 2023-2024 | Xarelto |
| Lilly USA, LLC | $87.24 | 2020-2025 | Mounjaro, Zepbound |
| Johnson & Johnson Health Care Systems INC. | $84.48 | 2023-2025 | Opsumit, Uptravi |
| Scpharmaceuticals INC. | $58.98 | 2023-2024 | |
| Kiniksa Pharmaceuticals, Ltd. | $45.90 | 2023 | Arcalyst |
| Cathworks, INC. | $41.85 | 2020 | |
| Abiomed | $38.26 | 2022 | |
| Teleflex LLC | $35.66 | 2025 | Guideliner |
| Boston Scientific Corporation | $25.42 | 2023 | Latitude Communicator Power Supply |
| Terumo Medical Corporation | $24.77 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $20.43 | 2021 | |
| Tactile Systems Technology INC | $13.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.